Clinical trials recruiting for Nab-paclitaxel
3
Recruiting trials
0
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Nab-paclitaxel + Carboplatin | 2 |
| Adjuvant therapy | 1 |
| Nab-paclitaxel + Capecitabine | 1 |
| Nab-paclitaxel + Epirubicin | 1 |
| Neoadjuvant therapy | 1 |
Self-screener
Recruiting trials
- Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Capecitabine in the Treatment of Advanced Triple-negative Breast Cancer
- Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast Cancer
- Tislelizumab Combined With Anlotinib and Nab-paclitaxel in III Resectable Non-small Cell Lung Cancer : A Prospective, Single-Arm, Phase II Study
Related conditions
Trials recruiting for Nab-paclitaxel often also study these conditions. Each links to its own recruiting-trial list.
Triple-negative breast cancer 138Breast cancer 2239Tislelizumab 4Non-small cell lung cancer 507Lung cancer 2180
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Nab-paclitaxel trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.